Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Anti-inflammatory is a broad pharmacological class encompassing multiple molecular targets involved in reducing or modulating inflammation. These targets include COX enzymes, LOXs, NF-kB pathway components, cytokines/receptors, and the JAK/STAT pathway. Anti-inflammatory agents work by inhibiting enzyme activity, suppressing proinflammatory signals, modulating transcription factors, interfering with cell adhesion, and enhancing endogenous anti-inflammatory pathways.
Inhibition/modulation of enzyme activity; suppression/blockade of proinflammatory signals; modulation of transcription factors; interference with cell adhesion; enhancement of endogenous anti-inflammatory pathways.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Anti-inflammatory.